Abstract:Graphical and Lay Summary NADPH‐dependent oxidoreductases are important catalysts for production of chiral compounds, but insufficient supply of expensive nicotinamide cofactors have prevented their widespread exploitation. In this study, the authors developed a metabolic engineering strategy and a multienzyme modulation strategy for a NADPH‐dependent glufosinate dehydrogenases (GluDH) whole‐cell biocatalytic system to enhance intracellular NADP+ pool and catalytic efficiency. The cofactor self‐sufficient whole‐cell biocatalystic system was successfully applied for the asymmetric synthesis of L‐phosphinothricin, afformed a super high space‐time yield without the need to add exogenous cofactors. The engineering strategy might serve as a useful approach for constructing a cofactor self‐sufficient system of other oxidoreductases. NAD(P)H‐dependent oxidoreductases are crucial biocatalysts for synthesizing chiral compounds. Yet, the industrial implementation of enzymatic redox reactions is often hampered by an insufficient supply of expensive nicotinamide cofactors. Here, a cofactor self‐sufficient whole‐cell biocatalyst was developed for the enzymatic asymmetric reduction of 2‐oxo‐4‐[(hydroxy)(‐methyl)phosphinyl] butyric acid (PPO) to L‐phosphinothricin (L‐PPT). The endogenous NADP+ pool was significantly enhanced by regulating Preiss‐Handler pathway toward NAD(H) synthesis and, in the meantime, introducing NAD kinase to phosphorylate NAD(H) toward NADP+. The intracellular NADP(H) concentration displayed a 2.97‐fold increase with the strategy compared with the wild‐type strain. Furthermore, a recombinant multi‐enzyme cascade biocatalytic system was constructed based on the Escherichia coli chassis. In order to balance multi‐enzyme co‐expression levels, the strategy of modulating rate‐limiting enzyme PmGluDH by RBS strengths regulation successfully increased the catalytic efficiency of PPO conversion. Finally, the cofactor self‐sufficient whole‐cell biocatalyst effectively converted 300 mM PPO to L‐PPT in 2 h without the need to add exogenous cofactors, resulting in a 2.3‐fold increase in PPO conversion (%) from 43% to 100%, with a high space‐time yield of 706.2 g L−1 d−1 and 99.9% ee. Overall, this work demonstrates a technological example for constructing a cofactor self‐sufficient system for NADPH‐dependent redox biocatalysis.

High-yield porphyrin production through metabolic engineering and biocatalysis

High-Level Bio-Based Production of Coproporphyrin in Escherichia coli

Sustainable production of porphyrins through synthetic biology

Enhanced Production of High-Value Porphyrin Compound Heme by Metabolic Engineering Modification and Mixotrophic Cultivation of Synechocystis sp. PCC6803

Bioproduction of porphyrins, phycobilins, and their proteins using microbial cell factories: engineering, metabolic regulations, challenges, and perspectives

Recent Advances in the Production of High-Value Products of Porphyrin Metabolism Pathways and Their Microbial Synthesis

Multi-modular metabolic engineering of heme synthesis in Corynebacterium glutamicum

Development of a growth-coupled selection platform for directed evolution of heme biosynthetic enzymes in Corynebacterium glutamicum

Synergistic Increase in Coproporphyrin III Biosynthesis by Mitochondrial Compartmentalization in Engineered Saccharomyces Cerevisiae

Cell-Free Optimized Production of Protoporphyrin IX

Developing a Highly Efficient Hydroxytyrosol Whole-Cell Catalyst by De-Bottlenecking Rate-Limiting Steps

ATP and NADPH engineering of Escherichia coli to improve the production of 4-hydroxyphenylacetic acid using CRISPRi

High-level co-production of 3-hydroxypropionic acid and 1,3-propanediol from glycerol: Metabolic engineering and process optimization

Engineering the Methylerythritol Phosphate Pathway and Using a Temporal Promoter for Enhanced Lycopene Production in Rhodobacter Sphaeroides HY01

Rational Design of Key Enzymes to Efficiently Synthesize Phycocyanobilin in Escherichia coli

Design of a cofactor self‐sufficient whole‐cell biocatalyst for enzymatic asymmetric reduction via engineered metabolic pathways and multi‐enzyme cascade

Optimization of trans-4-hydroxyproline synthesis pathway by rearrangement center carbon metabolism in Escherichia coli

Adaptive evolutionary strategy coupled with an optimized biosynthesis process for the efficient production of pyrroloquinoline quinone from methanol

Enhancing Phycocyanobilin Production Efficiency in Engineered Corynebacterium glutamicum: Strategies and Potential Application.

Production of zinc protoporphyrin IX by metabolically engineered Escherichia coli

Metabolic Engineering of Pichia Pastoris for High-Level Production of Lycopene.